The ownership of scientific results is crucial in research, and figuring out who owns the results and intellectual property can be very challenging.

In academia, most intellectual property is owned by universities, which complicates the process for researchers wanting to commercialize their discoveries.

There's increasing acceptance of transitioning from academia to industry, as innovations often stem from academic research, and pursuing entrepreneurship can be a viable path for scientists. Most drugs on the market originate from discoveries made in academia, which are then commercialized by biotech or pharmaceutical companies.

Intellectual property (IP) is crucial in biotech; owning IP is necessary to justify the investment in development and clinical studies.

Universities have gained credibility from hard sciences, but this has led to the corruption of science itself, particularly in social sciences.

Providing a path for PhD students and postdocs to become entrepreneurs can leverage their deep knowledge of scientific discoveries for company success.

There's a significant opportunity for students to transform their academic discoveries into real-world applications by creating companies.

Biotech founders often make the mistake of not conducting the essential experiments needed to validate their ideas, fearing that failure could jeopardize their startups.

In hard tech, companies often need to be frugal and agile, testing products quickly to see if they resonate with the market, rather than over-investing in development before validating the idea. If you're a scientist or engineer considering commercializing your work, get out of your comfort zone and engage with potential customers to validate your product idea.